[Bronchial arterial infusion chemotherapy in the treatment of stage III non-small cell lung cancer]

Q Li; P Tao; Y Han; L Peng; J Zhu; F Xu; G Wang; G Xu

doi:10.3779/j.issn.1009-3419.2001.04.08

[Bronchial arterial infusion chemotherapy in the treatment of stage III non-small cell lung cancer]

Zhongguo Fei Ai Za Zhi. 2001 Aug 20;4(4):272-4. doi: 10.3779/j.issn.1009-3419.2001.04.08.

[Article in Chinese]

Authors

Q Li¹, P Tao, Y Han, L Peng, J Zhu, F Xu, G Wang, G Xu

Affiliation

¹ Department of Surgery , Sichuan Cancer Hospital, Chengdu, Sichuan 610041, P . R. China.

PMID: 21050577
DOI: 10.3779/j.issn.1009-3419.2001.04.08

Abstract

Background: To explore the methods of comprehensive treatment of stage III non-small cell lung cancer ( NSCLC) .

Methods: Treating group consisting of fifty patients with stage III NSCLC was treated with interventional chemotherapy, surgical treatment and radiotherapy, and 42 patients as control.

Results: Resection rate in treating group was 94. 0% after interventional chemotherapy, and 84. 0% of the group got radical resection. The 1-, 3-, 5-year survival rates were 44. 0%, 36. 0%, and 22. 0% in the treating group, and were 23. 8%, 16. 7% and 7. 1% respectively in control group ( P < 0. 05) .

Conclusions: Standard comprehensive treatment is helpful to improve curative effect of stage III NSCLC.

Publication types

English Abstract